Abstract
Apoptosis plays a pivotal role in portal tract damage of primary biliary cirrhosis (PBC). Tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is an apoptotic inducer, and it has been reported that the expression of TRAIL receptors is up-regulated by increased bile acid level and the serum level of soluble TRAIL (sTRAIL) is elevated in PBC patients. In the present study, we investigated the association of TRAIL in peripheral blood with the pathogenesis of PBC and chronic hepatitis B. The expression levels of TRAIL mRNA and protein on leukocytes and sTRAIL in plasma from 27 patients with PBC, 25 with CHB and 30 healthy controls were determined respectively by real-time fluorescent quantitative reverse transcription polymerase chain reaction (RT-PCR), flow cytometry (FCM) and ELISA. The expression levels of TRAIL mRNA and protein on leukocytes and plasma sTRAIL were all up-regulated in the patients with PBC and CHB compared to controls. In the two diseased groups, TRAIL mRNA showed significant correlation of both membrane-bound TRAIL (mTRAIL) on monocytes and plasma sTRAIL. So did plasma TNF-α. In PBC patients, mTRAIL and sTRAIL correlated well with γ-glutamyltransferase and alkaline phosphatse, but not with aspartate aminotransferase and alanine amino-transferase. The opposite case was found in CHB patients. These results suggested that both mTRAIL and sTRAIL might be involved in the development and progression of PBC and CHB in humans, but the mechanisms might be different.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Harada K, Nakanuma Y (2006) Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol 39:55–61
Tinmouth J, Lee M, Wanless IR et al (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22:228–234
Iwata M, Harada K, Kono N et al (2000) Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum Pathol 31:179–184
Harada K, Ozaki S, Gershwin ME et al (1997) Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26:1399–1405
Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682
LeBlanc HN, Ashkenazi A (2003) Apo 2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66–75
Rus V, Zernetkina V, Puliaev R et al (2005) Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin Immunol 117:48–56
Huang Y, Erdmann N, Peng H et al (2005) The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2:113–122
Cretney E, McQualter JL, Kayagaki N et al (2005) TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 83:511–519
Baba N, Kobashi H, Yamamoto K et al (2006) Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. Translational Res 148:103–113
Pelli N, Floreani A, Torre F et al (2007) Soluble apoptosis molecules in primary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. Clin Exp Immunol 148:85–89
Heathcote EJ (2000) Management of primary biliary cirrhosis. Hepatology 31:1005–1013
Jo M, Kim TH, Seol DW et al (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564–567
Higuchi H, Bronk SF, Taniai M et al (2002) Cholestasis increases tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. J Pharmacol Exp Ther 303:461–467
Floreani A, Baragiotta A, Martines D et al (2000) Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment Pharmacol Ther 14:353–358
Janssen HL, Higuchi H, Abdulkarim A et al (2003) Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. J Hepatol 39:414–420
Liang X, Liu Y, Zhang Q et al (2007) Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 178:503–510
Higuchi H, Bronk SF, Takikawa Y et al (2001) The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis. J Biol Chem 276:38610–38618
Higuchi H, Grambihler A, Canbay A et al (2004) Bile acids upregulate death receptor 5/TRAIL-receptor 2 expression via a c-jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279:51–60
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributed equally to this work
Rights and permissions
About this article
Cite this article
Liang, Y., Yang, Z., Li, C. et al. Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis. Clin. Exper.Med. 8, 1–7 (2008). https://doi.org/10.1007/s10238-008-0149-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-008-0149-z